Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Alto Neuroscience, Inc. (ANRO) had Weighted-Average Shares Outstanding (Diluted) of 27.10M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-14.18M |
|
-- |
|
-- |
|
$14.95M |
|
$-14.95M |
|
$0.77M |
|
$-14.18M |
|
$-14.18M |
|
$-14.18M |
|
$-14.18M |
|
$-14.18M |
|
$-14.18M |
|
$-14.95M |
|
$-14.79M |
|
27.10M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
27.10M |
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$139.45M |
|
$2.03M |
|
$7.56M |
|
$147.01M |
|
$9.04M |
|
$22.44M |
|
$26.40M |
|
$35.45M |
|
$111.56M |
|
$111.56M |
|
$111.56M |
|
27.17M |
|
| Cash Flow Statement Financials | |
$-40.25M |
|
$-0.02M |
|
$9.89M |
|
$168.73M |
|
$138.32M |
|
$-30.41M |
|
$6.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.42 |
|
-- |
|
-- |
|
0.17 |
|
0.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-40.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.71% |
|
-12.71% |
|
-9.65% |
|
-10.58% |
|
$4.11 |
|
$-1.49 |
|
$-1.49 |
|